OLHHA is a dual CB1 receptor antagonist and PPARalpha agonist. OLHHA also is a alcohol intake inhibitor with an EC50 value of 0.2 mg/kg. OLHHA reduces both hepatic lipid accumulation and circulating triglyceride levels. OLHHA shows anti-steatotic activity and has the potential for the research of non-alcoholic fatty liver disease (NAFLD)[1][2].
Molekulargewicht:
431.65
CAS Nummer:
[1258011-97-0]
Formel:
C27H45NO3
Target-Kategorie:
Cannabinoid Receptor,PPAR
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
